Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Balchem (BCPC) Cash & Equivalents (2016 - 2026)

Balchem (BCPC) has disclosed Cash & Equivalents for 17 consecutive years, with $72.9 million as the latest value for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 46.04% year-over-year to $72.9 million; the TTM value through Mar 2026 reached $72.9 million, up 46.04%, while the annual FY2025 figure was $74.6 million, 50.6% up from the prior year.
  • Cash & Equivalents hit $72.9 million in Q1 2026 for Balchem, down from $74.6 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $77.0 million in Q3 2023 and bottomed at $49.5 million in Q4 2024.
  • Average Cash & Equivalents over 5 years is $65.1 million, with a median of $65.1 million recorded in 2025.
  • Year-over-year, Cash & Equivalents crashed 37.24% in 2022 and then surged 50.6% in 2025.
  • Balchem's Cash & Equivalents stood at $66.6 million in 2022, then fell by 3.17% to $64.4 million in 2023, then decreased by 23.17% to $49.5 million in 2024, then soared by 50.6% to $74.6 million in 2025, then dropped by 2.28% to $72.9 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $72.9 million, $74.6 million, and $65.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.